Delivery Order SPE2DB20D1100-SPE2DB24FC1D6

Award Date 6/5/24
Potential Completion Date 6/27/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $34,331.38 delivery order contract is for the supply of OJJAARA 200 MG tablets. The contract is a Firm Fixed Price arrangement with an ultimate completion date of September 27, 2024. This award does not have a set-aside designation. Amerisourcebergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $34,331.38 Firm Fixed Price Delivery Order is for the supply of OJJAARA 200 MG TABLET UU 30S pharmaceutical products. The contract has no set-aside designation and has a period of performance through July 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) worth up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $17,165.69 delivery order contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of July 26, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,849.85 firm fixed-price delivery order contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a medical product. The contract has an ultimate completion date of February 4, 2025 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,165.69 delivery order is for the supply of OJJAARA 200 MG TABLET, with a completion date of November 27, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $34,425.52 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, with a completion date of March 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of OJJAARA 200 MG TABLET with a completion date of March 27, 2024 and a potential value of $17,165.69. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp serves as the prime contractor delivering pharmaceutical products and medical...
This federal contract award is a delivery order valued at $17,165.69 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The award was made by the Defense Logistics Agency (DLA), a defense agency, to provide 4565028708 - OJJAARA 200 MG TABLET UU 30S. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,758.95 firm fixed-price delivery order (SPE2DB22D2006|SPE2DB25FV6PA) is for the supply of OJJAARA 200 MG TABLET UU 30S, with a performance period through December 2024. This award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $34,331.38 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565469521 OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price type with a completion date of September 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of the company's...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC1D6
    Delivery Order

This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,165.69 Firm Fixed Price Delivery Order is for the supply of 4564821265 OJJAARA 200 MG TABLET UU 30S, with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/4/24, 9:16 AM